Pipeline Embolization Device for the Treatment of Intracranial Aneurysms-A Real World Study on the Long Term Safety and Efficacy(POWER)
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
Since its launch in China in 2014, Pipeline Embolization Device (PED) has been widely used in the treatment of intracranial aneurysms. It is necessary to collect data on the long-term safety and efficacy of the Pipeline Embolization Device (PED) in the treatment of intracranial aneurysms, analyze its long-term effectiveness, and provide guidance for clinical practice.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• The patient was diagnosed with intracranial aneurysms using digital subtraction angiography (DSA).
• The pipeline was successfully placed to treat intracranial aneurysms.
Locations
Other Locations
China
Xuanwu Hospital, Capital Medical University
RECRUITING
Beijing
Contact Information
Primary
peng zhang, MD
zhangpengwr@126.com
010-83198899
Backup
Yongjie Ma, MD
mayongjiedoctor@sina.com
010-83198899
Time Frame
Start Date: 2021-12-30
Estimated Completion Date: 2024-12-30
Participants
Target number of participants: 482
Related Therapeutic Areas
Sponsors
Collaborators: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Qilu Hospital of Shandong University, Nanfang Hospital, Southern Medical University, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Henan Provincial People's Hospital, The First Affiliated Hospital of Zhengzhou University, First Affiliated Hospital of Xinjiang Medical University, Beijing Tiantan Hospital, Second Affiliated Hospital of Nanchang University
Leads: Xuanwu Hospital, Beijing